Radiolabelled tracking study employs radioactive markers quantitating drug tissue distribution and excretion. Carbon-14 or hydrogen-3 labelling tracks organic drugs. Positron emission tomography enables imaging. Whole-body autoradiography visualises distribution. Excretion route characterisation informs elimination understanding.
Regulatory submissions include radiolabelled study data. Metabolism pathway identification guides drug design. Tissue accumulation assessment informs safety. Post-approval monitoring confirms predicted distribution. Emerging imaging technologies reduce radiation exposure.
General Biopharmaceutical Concepts
Radiolabelled Tracking Study
A radiolabelled tracking study uses radioactive labels to monitor the distribution, metabolism or elimination of compounds within biological systems.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →